Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
18:54
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 20th Annual Conference
    Topic - Therapy & Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 109
Visits: 93
Title: Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study.
Authors: Petros Fessas , P. FESSAS, A. KASEB, Y. WANG, A. SAEED, D. SZAFRON, T. JUN, S. DHARMAPURI, A.R. NAQASH, M. MUZAFFAR, M. NAVAID, U. KHAN, C. LEE, A. BULUMULLE, B. YU, S. PAUL, N. NIMKAR, D. BETTINGER, F. BENEVENTO, H. HILDEBRAND, T. PRESSIANI, Y.I. ABUGABAL, N. PERSONENI, Y-H. HUANG, L. RIMASSA, C. ANG, T.U. MARRON, D.J. PINATO
Centre: 

You must be registered to reply or comment.

POST-REGISTRATION EXPERIENCE OF NIVOLUMAB THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC): AN INTERNATIONAL STUDY.

Petros Fessas
Thread initiator
Subspeciality
Reg: 8/19/2020 3:53:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 9/22/2020 1:28:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre: 

Poster most viewed in this topic
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert